Active Supportive Care and Symptom Management Grants

PI Namesort descending Organization - Company Title FOA
Basch, Ethan M. Univ Of North Carolina Chapel Hill Analyzing and Interpreting PRO-CTCAE with CTCAE and Other Clinical Data to Characterize Drug Tolerability RFA-CA-17-052: Analyzing and Interpreting Clinician and Patient Adverse Event Data to Better Understand Tolerability
Gray, Robert J Dana-Farber Cancer Inst Analysis of ECOG-ACRIN adverse event data to optimize strategies for the longitudinal assessment of tolerability in the context of evolving cancer treatment paradigms (EVOLV) RFA-CA-17-052: Analyzing and Interpreting Clinician and Patient Adverse Event Data to Better Understand Tolerability
Hui, David University Of Tx Md Anderson Can Ctr A Randomized Controlled Trial of Dexamethasone for Dyspnea in Cancer Patients PA-16-160: NIH Research Project Grant
Hui, David University Of Tx Md Anderson Can Ctr Efficacy and Safety of Rapid-Onset Opioids for Exertional Dyspnea in Cancer Patients PAR-18-559: Cancer Prevention and Control Clinical Trials Grant Program
Krause, Diane S Yale University "Exploration of Human Parathyroid Cellular Organization and Function" PAR-19-356: NCI Clinical and Translational Exploratory/Developmental Studies
Miaskowski, Christine A. University Of California, San Francisco Impact of Hearing Loss and Tinnitus in Cancer Survivors PA-16-160: NIH Research Project Grant
Mohile, Supriya G University Of Rochester Understanding Treatment Tolerability in Older Patients with Cancer RFA-CA-17-052: Analyzing and Interpreting Clinician and Patient Adverse Event Data to Better Understand Tolerability
Rogatko, Andre Cedars-Sinai Medical Center Advancing Analysis and Interpretation ofAdverse Events and PROs in Cancer Clinical Trials RFA-CA-17-052: Analyzing and Interpreting Clinician and Patient Adverse Event Data to Better Understand Tolerability
Sanft, Tara B Yale University A randomized trial of lifestyle guidelines on breast cancer biomarkers and treatment adherence PAR-16-122: Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival
Sherman, Larry S Oregon Health & Science University Hyaluron as a regulator of chemotherapy-induced changes in neurogenesis PA-16-258: Mechanisms of Cancer and Treatment-related Symptoms and Toxicities
Sorror, Mohamed Fred Hutchinson Cancer Center Novel Intervention Approaches to Alleviate Allogeneic Transplant-Related Morbidity and Mortality PA-17-018: Palliative Care Needs of Individuals with Advanced Rare Diseases and Their Family Caregivers
Stover, Daniel G. Ohio State University Video Intervention to Address Pre-Test Patient Education for Tumor Genomic Testing PAR-19-356: NCI Clinical and Translational Exploratory/Developmental Studies
Strati, Paolo University Of Tx Md Anderson Can Ctr Targeting Myeloid Cells to Mitigate Immune Effector Cell-Associated Neurotoxicity Syndrome in Large B-cell Lymphoma PAR-19-356: NCI Clinical and Translational Exploratory/Developmental Studies